Personalizing Management of Limited mCRC: A Call for More Evidence

Dr. George J. Chang Article Highlights While curative-intent treatment of patients with oligometastatic colorectal cancer is already considered standard practice, the role of local ablative therapies to render patients disease free is less clear in patients with multisite, limited disease who would not be traditionally considered candidates for curative resection. Advances…

Read the full article here

Related Articles